Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Who Underwent Complete Revascularization : A Randomized Controlled Trial

NCT07736196 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07736196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07736196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Who Underwent Complete Revascularization : A Randomized Controlled Trial
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
June 1, 2030
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs) undergoing percutaneous coronary intervention (pci), dual anti-platelet therapy